Jane Street
GRCL

Jane Street’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Jane Street’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,840
Closed -$20.2K – 9829
2023
Q1 		$20.2K Buy
+10,840
New +$22.7K ﹤0.01% 8646
2022
Q2 		– Sell
-13,340
Closed -$31K – 11247
2022
Q1 		$31K Buy
+13,340
New +$45.5K ﹤0.01% 9823

Other funds holding GRCL

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street's GRCL Position: Q2 2023 in Review

Jane Street sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q2 2023, closing a stake of 10,840 shares — an estimated $20.2K sold.

Jane Street first reported a position in GRCL in Q1 2022 and held it in 2 quarters. The position peaked at $31K in Q1 2022. 36 funds tracked by Wall St. Rank hold GRCL as of Q2 2023.

  • Jane Street reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Jane Street sold 10,840 Gracell Biotechnologies Inc. American Depositary Shares shares in Q2 2023, an estimated $20.2K.
  • Jane Street first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q1 2022 and held it in 2 quarters.
  • Jane Street's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $31K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.